ut-logo website  
Register and login to access premium content
Log in
Express registration and login!
If you have a Facebook or LinkedIN account, use one of the buttons on the left to either login or create a new account.

Log in


AUA 2013 - Session Highlights: Development and validation of the biopsy-based genomic prostate score (GPS) as a predictor of high grade or extracapsular prostate cancer to improve patient selection for active surveillance

SAN DIEGO, CA USA (UroToday.com) - Active surveillance (AS) is gaining momentum in this era of prostate cancer over-diagnosis and overtreatment, and many efforts are on the way to better risk-stratify patients prior to the intervention. To read more, a FREE Urotoday registration is required. Click here to register or login above.
To read UIJ content, a separate subscription is required.